Expression of the estrogen receptor gene in developing and adult human breast

Breast Cancer Research and Treatment

Volumn 37, Issue 3, 1996, Pages 243-251

  Boyd, Marie T ^a   Hildebrandt, Richard H ^a   Bartow, Sue A ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Breast development; Estrogen receptor; Fibrocystic change; Gene expression

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GENE PRODUCT; HORMONE; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CHILD; FEMALE; FIBROCYSTIC BREAST DISEASE; FOLLICULAR PHASE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; INFANT; LUTEAL PHASE; MENARCHE; MENOPAUSE; MESSENGER RNA SYNTHESIS; NORMAL HUMAN; PHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; STAINING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; RECEPTORS, ESTROGEN; RNA, MESSENGER;

EID: 0030034154     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806506     Document Type: Article

References (49)

1. Drife JO: Breast development in puberty. Ann NY Acad Sci 464: 58-65, 1986
2. Muldoon TG: Steroid hormone receptor regulation by various hormonal factors during mammary development and growth in the normal mouse. Ann NY Acad Sci 464: 17-36, 1986
3. Marshal E: Epidemiology. Search for a killer focus shifts from fat to hormones (news). Science 259: 618-221, 1993
4. Hulka BS, Liu ET, Lininger RA: Steroid hormones and risk of breast cancer. Cancer 74: 1111-1124, 1994
5. O'Malley BW, Means AR: Female steroid hormones and target cell nuclei. Science 183: 610-620, 1974
6. Horwitz KB, McGuire WL: Nuclear mechanisms of estrogen action. J Biol Chem 253: 8185-8191, 1978
7. Carson-Jurica MA, Schrader WT, O'Malley BW: Steroid receptor family: structure and functions. Endocrine Reviews 11: 201-220, 1980
8. Katzenellenbogen BS: Dynamics of steroid hormone receptor action. Ann Rev Physiol 42: 17-35, 1980
9. Ringold GM: Steroid hormone regulation of gene expression. Ann Rev Pharmacol Toxicol 25: 529-566, 1985
10. Yamamoto K: Steroid receptor regulated transcription of specific genes and gene networks. Ann Rev Genet 19: 209-252, 1985
11. King RJB: Oestrogen-receptors: an overview of recent advances in their structure and function. Proc Royal Soc Edinburgh 95B: 133-144, 1989
12. McCarty KS Jr: Proliferative stimuli in the normal breast: estrogens of progestins? Human Pathol 20: 1137-1138, 1989
13. Peterson OW, Hoyer PE, van Deurs B: Frequency and distribution of estrogen receptor-positive cells in normal, non-lactating human breast tissue. Cancer Res 47: 5748-5751, 1987
14. Markopoulos C, Berger U, Wilson P, Gazet J-C, Coombes RC: Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J 296: 1349-1351, 1988
15. Carpenter S, Georgiade G, McCarty KS Sr, McCarty KS Jr: Immunohistochemical expression of oestrogen receptor in normal breast tissue. Proc Royal Soc Edinburgh 95B: 59-66, 1989
16. Jacquemier JD, Hassoun J, Torrente M, Martin PM: Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages - immunohistochemical study of 107 cases. Breast Cancer Res Treat 15: 109-117, 1990
17. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NSB, Gazet J-C, Nolan C, Coombes RC: Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817-1822, 1991
18. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, Patten CS: Oral contraceptive (OCP) use increases proliferative and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48: 206-210, 1991
19. Battersby S, Robertson BJ, Anderson TJ, King RJB, McPherson K: Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 65: 601-607, 1992
20. Feherty P, Farver-Brown G, Kellie AE: Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay. Br J Cancer 25: 697-710, 1971
21. Rosen PP, Menendez-Botet CJ, Nisselbaum JS, Urban JA, Miké V, Fracchia A, Schwartz MK: Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res 35: 3187-3194, 1975
22. Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P: Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem 9: 1251-1255, 1978
23. Allegra JC, Lippman ME, Green L, Barlock A, Simon R, Thompson EB, Huff KK, Griffin W: Estrogen receptor values in patients with benign breast disease. Cancer 44: 228-231, 1979
24. Giani C, D'Amore E, Delarue JC, Mouriesse H, May-Levin F, Sancho-Garnier H, Breccia M, Contesso G: Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features. Int J Cancer 37: 7-10, 1986
25. Brentani MM, Franco EL, Oshima CTF, Pacheco MM: Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach. Int J Cancer 38: 637-642, 1986
26. Balakrishnan A, Yang J, Beattie CW, Das Gupta TK, Nandi S: Estrogen receptor in dissociated and cultured human breast fibroadenoma epithelial cells. Cancer Letters 34: 233-242, 1987
27. Longacre TA, Bartow SA: A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382-393, 1986
28. Vogel PM, Georgiade NG, Fetter BJ, Vogel FS, McCarty KS Jr: The correlation of histological changes in the human breast with the menstrual cycle. Am J Pathol 104: 23-34, 1981
29. Cancer Committee of the College of American Pathologists. Is fibrocystic disease of the breast precancerous? A consensus meeting, October 3 to October 5, 1981: New York. Arch Pathol Lab Med 110: 171-173, 1986
30. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979
31. Lehrach H, Diamond D, Wozney JM, Boedtker J: RNA molecular weight determination by gel electrophoresis under denaturing conditions; a critical re-examination. Biochemistry 16: 4743-4751, 1977
32. Bonini JA, Hofmann C: A rapid, accurate, non-radioactive method for quantitating RNA on agarose gels. Biotechniques 11: 708-709, 1991
33. Correa-Rotter R, Mariash CN, Rosenberg ME: Loading and transfer control for northern hybridization. Biotechniques 12: 154-158, 1992
34. Walter P, Green S, Greene G, Krust A, Bornert J-M, Jeltsch J-M, Staub A, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci 82: 7889-7893, 1985
35. Greene GL, Press MF: Structure and dynamics of the estrogen receptor. I. Steroid receptor structure (including monoclonal antibodies and new methods of determination). J Steroid Biochem 24: 1-7, 1986
36. Ree AH, Landmark BF, Eskild W, Levy FO, Lahooti H, Johnsen T, Aakvaag A, Hanson V: Autologous down-regulation of messenger ribonucleic acid and protein levels of estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Endocrinology 124: 2577-2583, 1989
37. Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM: Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313: 231-233, 1985
38. Eidne KA, Flanagan CA, Harris NS, Millar RP: Gonadotropin releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 64: 425-432, 1987
39. Fekete M, Bajusz S, Groot K, Csernus V, Schally AV: Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes. Endocrinology 946-955, 1989
40. Keri G, Balogh A, Szoke B, Teplan I, Csuka O: Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line. Tumor Biol 12: 61-67, 1991
41. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P: Functional domains of the human estrogen receptor. Cell 51: 941-951, 1987
42. Kumar V, Chambon P: The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145-156, 1988
43. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3385-3388, 1988
44. Wahli W, Martinez E: Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J 5: 2243-2249, 1991
45. van der Burg B, van Selm-Miltenburg AJP, de Laat SW, van Zoelen EJJ: Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol 64: 223-228, 1989
46. Aronica SM, Katzenellenbogen BS: Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′, 5′-monophosphate, and insulin-like growth factor I and suppression by anti-estrogens and protein kinase inhibitors. Endocrinology 128: 2045-2052, 1991
47. Mishell DR Jr, Davajan V: The menstrual cycle. In: Reproductive Endocrinology, Infertility and Contraception. Philadelphia, F.A. Davis Company, 1979, pp 67-89
48. Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181, 1981
49. Meyer JS: Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labelling with tritiated thymidine: effects of menstrual phase, age and oral contraceptive hormones. Human Pathol 8: 67-81, 1977